MYOV
Goldman Sachs’s Myovant Sciences Ltd. MYOV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,420,659
| Closed | -$65.3M | – | 5404 |
|
|
2022
Q4 | $65.3M | Buy |
2,420,659
+1,929,497
| +393% | +$52M | 0.02% | 806 |
|
|
2022
Q3 | $8.82M | Buy |
491,162
+72,826
| +17% | +$1.31M | ﹤0.01% | 2233 |
|
|
2022
Q2 | $5.2M | Buy |
418,336
+207,827
| +99% | +$2.58M | ﹤0.01% | 2614 |
|
|
2022
Q1 | $2.8M | Buy |
210,509
+21,019
| +11% | +$280K | ﹤0.01% | 3300 |
|
|
2021
Q4 | $2.95M | Buy |
189,490
+60,339
| +47% | +$939K | ﹤0.01% | 3208 |
|
|
2021
Q3 | $2.9M | Sell |
129,151
-49,594
| -28% | -$1.11M | ﹤0.01% | 3196 |
|
|
2021
Q2 | $4.07M | Sell |
178,745
-204,342
| -53% | -$4.65M | ﹤0.01% | 2940 |
|
|
2021
Q1 | $7.88M | Buy |
383,087
+249,313
| +186% | +$5.13M | ﹤0.01% | 2368 |
|
|
2020
Q4 | $3.7M | Sell |
133,774
-39,740
| -23% | -$1.1M | ﹤0.01% | 2663 |
|
|
2020
Q3 | $2.44M | Buy |
173,514
+88,576
| +104% | +$1.24M | ﹤0.01% | 2799 |
|
|
2020
Q2 | $1.75M | Buy |
84,938
+19,157
| +29% | +$395K | ﹤0.01% | 2908 |
|
|
2020
Q1 | $497K | Buy |
65,781
+13,265
| +25% | +$100K | ﹤0.01% | 3500 |
|
|
2019
Q4 | $815K | Buy |
52,516
+6,704
| +15% | +$104K | ﹤0.01% | 3423 |
|
|
2019
Q3 | $238K | Buy |
45,812
+26,967
| +143% | +$140K | ﹤0.01% | 3862 |
|
|
2019
Q2 | $171K | Buy |
+18,845
| New | +$171K | ﹤0.01% | 3915 |
|
|
2018
Q2 | – | Sell |
-9,444
| Closed | -$201K | – | 4369 |
|
|
2018
Q1 | $201K | Buy |
+9,444
| New | +$201K | ﹤0.01% | 3851 |
|
|
2017
Q3 | – | Sell |
-14,853
| Closed | -$174K | – | 4465 |
|
|
2017
Q2 | $174K | Buy |
+14,853
| New | +$174K | ﹤0.01% | 4018 |
|
|
2017
Q1 | – | Sell |
-464,635
| Closed | -$5.78M | – | 4581 |
|
|
2016
Q4 | $5.78M | Buy |
+464,635
| New | +$5.78M | ﹤0.01% | 2100 |
|